Zobrazeno 1 - 10
of 16
pro vyhledávání: '"M. Garijo Bufort"'
Autor:
J. L. Martín-Varillas, L. Sanchez-Bilbao, V. Calvo-Río, A. Adan, I. Hernanz Rodriguez, E. Beltrán, S. Castro, P. Fanlo Mateo, A. García Martos, I. Torre-Salaberri, M. Cordero-Coma, J. De Dios-Jiménez Aberásturi, Á. García-Aparicio, M. Hernández-Garfella, A. Sanchez-Andrade, A. García-Valle, R. Miguélez, O. Maiz, S. Rodríguez Montero, A. Urruticoechea-Arana, R. Veroz Gonzalez, A. Conesa, C. Fernández-Carballido, V. Jovani, O. Martínez González, P. Moya, S. Romero-Yuste, P. Rubio Muñoz, E. Peña Sainz-Pardo, M. Garijo Bufort, J. L. Hernández, R. Blanco
Publikováno v:
Annals of the Rheumatic Diseases. 81:1013.2-1014
BackgroundAdalimumab remains the only biologic approved by the EMA and FDA for the treatment of non-infectious uveitis [1-6]. The reports on efficacy of other anti-TNF drugs such as Certolizumab Pegol (CZP) are scarce.Objectivesto determine the effic
Autor:
J. L. Martín-Varillas, L. Sanchez-Bilbao, V. Calvo-Río, A. Adan, I. Hernanz Rodriguez, M. Cordero-Coma, D. Díaz Valle, P. Fanlo Mateo, J. De Dios-Jiménez Aberásturi, Á. García-Aparicio, S. Rodríguez Montero, V. Jovani, P. Moya, E. Peña Sainz-Pardo, M. Garijo Bufort, J. L. Hernández, R. Blanco
Publikováno v:
Annals of the Rheumatic Diseases. 81:1014-1014
BackgroundCystoid Macular Edema (CME) is the leading cause of blindness in non-infectious uveitis. Behçet’s disease (BD) is one of the diseases most frequently associated with CME [1-4].Objectivesto compare the efficacy and safety of Certolizumab
Autor:
C. Valero, M. Garijo Bufort, A. García-Valle, A. López Robles, Cruz Fernández-Espartero, C. Y. Soleto, Javier Loricera, M. Retuerto-Guerrero, José L. Pablos, Elena Aurrecoechea, E. Trujillo
Publikováno v:
Annals of the Rheumatic Diseases. 79:648-649
Background:Different Jakinibs (JAKi) have shown efficacy in rheumatoid arthritis (RA) but in an important proportion of patients, insufficient response leads to therapy withdrawal. The different JAKi show variable selectivity for the four Jak isoform
Autor:
T. Pérez Sandoval, A. Crespo Golmar, C. Iñiguez Ubiaga, M. Garijo Bufort, M. Martín Martínez, Clara Moriano, E. Diez Alvarez, A. López Robles, I. GonzalezFernandez, C. Álvarez Castro
Publikováno v:
Public health, health services research and health economics.
Background The lack of treatment adherence to is considered the main reason for therapeutic failure. It entails a high health care cost, both direct and indirect, affecting the patient‘s morbidity and mortality. In order to measure this adherence,
Autor:
E. Diez Alvarez, C. Iñiguez Ubiaga, A. López Robles, A. Crespo Golmar, I. González Fernández, M. Garijo Bufort, T. Pérez Sandoval, C. Álvarez Castro, C. Moriano Morales, M. E. Vallejo Pascual, M. Guerra González, M. Martín Martínez
Publikováno v:
Saturday, 16 JUNE 2018.
Background Denosumab (DB) is a monoclonal antibody to RANK ligand that, like all biological drugs, can be associated with an increased risk of infections. However, there are few studies concerning the risk of infection in these patients treated conco
Autor:
L Sierra Herranz, M. Garijo Bufort, A. Crespo Golmar, A Lόpez Robles, M. Retuerto Guerrero, E Άlvarez Díez, C Άlvarez Castro, C. Iñiguez Ubiaga, T. Pérez Sandoval, C. Moriano Morales, M Martínez Martín
Publikováno v:
Abstracts Accepted for Publication.
Background The Sjogren syndrome (SS) is an autoimmune disease where the cellular and humoral mechanisms affect the exocrine glands. In 2016, new classification criteria validated by ACR and EULAR were established. Objectives To compare the new criter
Autor:
C. Moriano Morales, E. Díez Άlvarez, C. Iñiguez Ubiaga, A. Crespo Golmar, A Lόpez Robles, T. Pérez Sandoval, E. Vallejo Pascual, C Άlvarez Castro, M. Retuerto Guerrero, M. Garijo Bufort, M. Martín Martínez
Publikováno v:
Poster Presentations.
Background Sarcoidosis is a systemic granulomatous disease, being the joint involvement a poorly studied manifestation. Objectives To describe the clinical and demographic characteristics of patients with sarcoidosis, paying particular attention to t
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.